<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-B4Z2980V/fadb931d-3e92-45dc-a7ca-827d116fa635/PDF"><dcterms:extent>140 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-B4Z2980V/626f6da4-46a4-4fcc-a0a4-d3ccce37aea9/TEXT"><dcterms:extent>21 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-B4Z2980V"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2004</dcterms:issued><dc:creator>Bergant Marušič, Martina</dc:creator><dc:creator>Jeras, Matjaž</dc:creator><dc:creator>Repnik, Urška</dc:creator><dc:format xml:lang="sl">str. I-69-I-72</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID_HOST:17681113</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-B4Z2980V</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Antigen Presentation</dc:subject><dc:subject xml:lang="sl">Antigen, predstavitev</dc:subject><dc:subject xml:lang="sl">Antigeni, CD</dc:subject><dc:subject xml:lang="sl">Antigens, Cd</dc:subject><dc:subject xml:lang="sl">Celične kulture</dc:subject><dc:subject xml:lang="sl">Cells, Cultured</dc:subject><dc:subject xml:lang="sl">Dendritic Cells</dc:subject><dc:subject xml:lang="sl">Dendritične celice</dc:subject><dc:subject xml:lang="sl">Limfocit, transformacija</dc:subject><dc:subject xml:lang="sl">Limfociti T</dc:subject><dc:subject xml:lang="sl">Lymphocyte Transformation</dc:subject><dc:subject xml:lang="sl">T-Lymphocytes</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Lastnosti in možnosti uporabe dendritičnih celic, antigensko specifičnih modulatorjev imunskega odziva| Characteristics and potential therapeutic applications of dendritic cells, antigen specific modulators of immune responses|</dc:title><dc:description xml:lang="sl">Background. Since the discovery of dendritic cells (DC) more than 30 years ago, several types of DC have been isolated in mouse and human and methods fortheir in vitro generation have been developed, Their general characteristics are, the extensive expression of MHC class 11 molecules on their cell surfaces, the ability to take up, process and present antigens, selective migration through tissues and interaction with lymphocytes. Once they were reknown for their stimulatory role in T cell proliferation and CTL generation but tolerogenic types have since been described which cantribute tothe maintenance of tolerance to self antigens. Cructial for the defence against pathogens are Langerhans cells and dermal or interstitial DC that reside in the peripheral tissues and take up antigens. Then they migrate to lymph nodes or spleen and present the antigens to T cells. If infectious or inflammatory signals/factors are present in the periphery, DC begin to expresscostimulatory molecules and secrete cytokanes which enable them to trigger immune response, and in addition, influence its characteristics and shape the effector mechanisms. Conclusions. There is a great hope that in the near future ex vivo differentiated DC, equipped with selected antigens could be used for the treatment of cancer, autoimmune diseases and for the prevention of rejections following tissue and organ transplantations</dc:description><dc:description xml:lang="sl">Izhodišča. Od prvega odkritja dendritičnih celic (DC) pred 30 leti so pri mišiin človeku osamili številne vrste DC ter razvili tudi postopke za njihovo pripravo in vitro. Med osnovne značilnosti omenjenih celic sodijo: izražanje velikega števila molekul MHC razreda II na njihovi površini; privzemanje, predelava in predstavljanje antigenov; potovanje skozi tkiva in tesno sodelovanje z limfociti. Sprva so jim pripisovali le vlogo pri spodbujanju proliferacije limfocitov T in nastanka citotoksičnih limfocitov T. Danes pa poznamo tudi takšne DC, ki sodelujejo pri vzdrževanju tolerance za lastne antigene. Za obrambo telesa pred patogenimi organizmi so ključne Langerhansovecelice ter dermalne ali intersticijske DC, ki naseljujejo periferna tkiva. Tam privzemajo antigene, nato pa se preselijo v sekundarne limfne organe, kjer jih ponujajo v prepoznavo limfocitom T. Če so v tkivih prisotne molekule, značilne za vnetje ali okužbo, začnejo DC na svojih površinah izražati kostimulacijske molekule ter izdelovati citokine. S tem DC ne le sprožijo nastanek imunskega odziva, temveč tudi vplivajo na njegove lastnosti in krojijo njegove efektorske mehanizme. Zaključki. Za ne tako oddaljeno prihodnost načrtujejo, da bodo lahko z DC diferenciranimi ex vivo ter opremljenimi s pojubnimi antigeni, zdravili raka in avtoimunske bolezni ter preprečevali neželene zavrnitvene reakcije po presaditvah tkiv in organov</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-B4Z2980V"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-B4Z2980V" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-B4Z2980V/fadb931d-3e92-45dc-a7ca-827d116fa635/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-B4Z2980V/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-B4Z2980V" /></ore:Aggregation></rdf:RDF>